| Product NDC: | 0187-2206 |
| Proprietary Name: | CeraVe |
| Non Proprietary Name: | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone |
| Active Ingredient(s): | 4.23; 21.15; 7.05; 14.1; 8.46 g/141g; g/141g; g/141g; g/141g; g/141g & nbsp; Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SPRAY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-2206 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20121128 |
| Package NDC: | 0187-2206-01 |
| Package Description: | 141 g in 1 TUBE (0187-2206-01) |
| NDC Code | 0187-2206-01 |
| Proprietary Name | CeraVe |
| Package Description | 141 g in 1 TUBE (0187-2206-01) |
| Product NDC | 0187-2206 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone |
| Dosage Form Name | SPRAY |
| Route Name | TOPICAL |
| Start Marketing Date | 20121128 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE |
| Strength Number | 4.23; 21.15; 7.05; 14.1; 8.46 |
| Strength Unit | g/141g; g/141g; g/141g; g/141g; g/141g |
| Pharmaceutical Classes |